Prednisone Use in CKD Stage 5

Pharmacokinetic Considerations

• Prednisone undergoes hepatic metabolism with minimal renal excretion, allowing for standard dosing protocols even in advanced CKD 1
• No specific dose adjustments are required based on GFR levels in CKD stage 5 patients 1
• Comprehensive medication management is essential due to pharmacokinetic alterations that occur with declining kidney function 1

Monitoring Recommendations

• Regular monitoring of serum creatinine and potassium levels is recommended when using corticosteroids in CKD patients 1
• Patients should be monitored weekly for changes in creatinine levels during corticosteroid treatment 2

Potential Risks and Precautions

• All corticosteroids increase calcium excretion, which may be particularly concerning in CKD patients who already have disturbed calcium metabolism 3
• Avoid combining corticosteroids with NSAIDs in CKD patients, as this combination may further impair renal function 1

Clinical Applications in CKD Stage 5

• In glomerular diseases requiring corticosteroid therapy, individualized approaches are needed based on disease type, severity, and CKD stage 1
• For HIV-associated nephropathy (HIVAN), prednisone (60 mg/day or 1 mg/kg/day) has shown benefit in improving renal function and reducing proteinuria 4